Month: March 2023

Announced Positive Results from Part 1 of Ongoing Phase 1b/2a Trial of BX004 for Treatment of Lung Infections in Cystic Fibrosis (“CF”) Patient Enrollment Continues in Part 2 of Phase 1b/2a Trial with Results Expected in Third Quarter of 2023 Cash Runway Through at Least Mid-2024 Company Will Host a Conference Call and Webcast Today at 8:00 am ET  CAMBRIDGE, Mass. and NESS ZIONA, Israel, March 29, 2023 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today reported financial results and provided a business update for the fourth quarter and full year ended December 31, 2022. “2023 is shaping up to be a very exciting year for our company, and the field of phage therapeutics. Based...

– Phenylketonuria (PKU) program on track for Phase 3 trial initiation in first half of 2023 – – Rare Pediatric Disease Designation granted for SYNB1934 for PKU and SYNB1353 for homocystinuria (HCU) – – Platform presentation and two poster presentations at SIMD Annual Meeting – – $77.6 million in cash, cash equivalents and marketable securities support projected runway into second half of 2024 –    CAMBRIDGE, Mass., March 29, 2023 (GLOBE NEWSWIRE) — Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today reported financial results for the fourth quarter and full year ending December 31, 2022 and provided a business update. “Last year was a tremendous year for Synlogic and our Synthetic Biotic platform given our three positive clinical readouts in three different diseases...

THE WOODLANDS, Texas, March 29, 2023 (GLOBE NEWSWIRE) — Conn’s, Inc. (NASDAQ: CONN) (“Conn’s” or the “Company”), a specialty retailer of home goods, including furniture, appliances and consumer electronics, with a mission to elevate home life to home love, today announced its financial results for the quarter and year ended January 31, 2023. “Our fourth quarter performance reflects the actions underway to refocus our efforts on serving our core credit constrained customers as we continue to face the impacts of macroeconomic headwinds and changes in consumer behavior. Providing multiple financing options is our key differentiator and we are pursuing profitable growth strategies aimed at enhancing the payment options we provide the tens of millions of consumers who visit our stores and website each year,” stated Norm Miller Interim...

Total revenue for full year 2023 expected to be $80.0 million – $120.0 million, up from full year 2022 revenue of $37.3 million Adjusted EBITDA for full year 2023 expected to be $(65.0) million – $(55.0) million versus full year 2022 Adjusted EBITDA of $(69.2) million Post-transaction total cash on hand of $230 million, positioning the Company with significant financial flexibility Cash position expected to fully fund the business through the achievement of positive Adjusted EBITDA expected by the end of 2024 CHICAGO, March 29, 2023 (GLOBE NEWSWIRE) — LanzaTech Global, Inc. (Nasdaq: LNZA) (“LanzaTech” or the “Company”), the leading Carbon Capture and Transformation (“CCT”) company, today announced its full year financial results for the fiscal year ending December 31, 2022, and provided its current outlook for full year 2023. 2022...

M3+ Delinquency Rate by Vintage M3+ Delinquency Rate by Vintage— Fourth Quarter Total Loan Origination Volume Grew 249.2% to RMB18.9 billion —— Fourth Quarter Net Income Grew 335.7% to RMB533.7 million —— Full Year Revenue Grew 83.7% to RMB3,271.4 million —— Full Year Net Income Grew 152.3% to RMB1,180.2 million — SHANGHAI, China, March 29, 2023 (GLOBE NEWSWIRE) — Jiayin Group Inc. (“Jiayin” or the “Company”) (NASDAQ: JFIN), a leading fintech platform in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2022. Fourth Quarter 2022 Operational and Financial Highlights:Loan origination volume1 was RMB18.9 billion (US$2.7 billion), representing an increase of 249.2% from the same period of 2021.  Average borrowing amount...